Dexamethasone intravitreal implant in the treatment of diabetic macular edema

Código QR

Dexamethasone intravitreal implant in the treatment of diabetic macular edema

Pravin U Dugel,1,2 Francesco Bandello,3 Anat Loewenstein4 1Retinal Consultants of Arizona, Phoenix, AZ, 2Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; 3Department of Ophthalmology, University Vita-Salute Scientific Institute San Raffa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dugel PU, Bandello F, Loewenstein A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/3b171be5303b474e81faad1b04045ebe
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Letter to the editor: dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Hall J
Publicado: (2015)

Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
por: Pacella E, et al.
Publicado: (2013)

Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema
por: Roc&iacute;o Herrero-Vanrell,&nbsp;Jose Augusto Cardillo, et al.
Publicado: (2011)

Intravitreal gas injection for the treatment of diabetic macular edema
por: McHugh D, et al.
Publicado: (2011)

Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants
por: Brynskov T, et al.
Publicado: (2013)

Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature
por: Sacchi M, et al.
Publicado: (2014)

Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
por: Lam WC, et al.
Publicado: (2015)

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
por: Ryder SJ, et al.
Publicado: (2015)

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter RS, et al.
Publicado: (2011)

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
por: Zola M, et al.
Publicado: (2017)

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Jane S Myung, et al.
Publicado: (2010)

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim M, et al.
Publicado: (2013)

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex&reg;) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
por: Chan A, et al.
Publicado: (2011)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon S, et al.
Publicado: (2014)

Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
por: Marey HM, et al.
Publicado: (2011)

Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema
por: Bandello F, et al.
Publicado: (2011)

Assessment of Reinjection Numbers and Intervals for Diabetic Macular Edema Patients Who Received Dexamethasone Intravitreal Implants in Germany and Switzerland
por: Augustin AJ, et al.
Publicado: (2021)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda SM, et al.
Publicado: (2017)

Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
por: Urbančič M, et al.
Publicado: (2019)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
por: Thomas BJ, et al.
Publicado: (2016)

Intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema
por: Elsawy MF
Publicado: (2012)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Juan Carlos Mesa Guti&eacute;rrez, et al.
Publicado: (2008)

Intravitreal triamcinolone for intraocular inflammation and associated macular edema
por: Steven M Couch, et al.
Publicado: (2008)

Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema
por: Saeed AM
Publicado: (2013)

Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema
por: Mushtaq B, et al.
Publicado: (2014)

Off-label use of intravitreal triamcinolone acetonide for diabetic macular edema in a pregnant patient
por: Fazelat A, et al.
Publicado: (2011)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine I, et al.
Publicado: (2017)

Topical nepafenac in the treatment of diabetic macular edema
por: David Callanan, et al.
Publicado: (2008)

A novel intravitreal fluocinolone acetonide implant (Iluvien®) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series
por: Schmit-Eilenberger VK
Publicado: (2015)

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema
por: O&#39;Day R, et al.
Publicado: (2013)

Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study
por: Chhablani J, et al.
Publicado: (2018)

Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy
por: He L, et al.
Publicado: (2011)

Critical appraisal of ranibizumab in the treatment of diabetic macular edema
por: Stewart MW
Publicado: (2013)

Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
por: Kiire CA, et al.
Publicado: (2015)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
por: Yalamanchi S, et al.
Publicado: (2011)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo P, et al.
Publicado: (2011)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
por: Coelho J, et al.
Publicado: (2019)

Adjunctive intravitreal dexamethasone in the treatment of acute endophthalmitis following cataract surgery
por: Edward F Hall, et al.
Publicado: (2008)

Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
por: Javier Obis, et al.
Publicado: (2021)

Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region
por: Wei W, et al.
Publicado: (2021)